艾媒咨询|2021年中国夜间用药年度观察报告
有您的支持，我们的分析师会做的更好 ！
本报告涉及的案例/品牌/企业：美团买药，叮当快药
在众多社会服务中，夜间用药成为人们最关注的夜间社会服务之一，近年来，各地相关行政管理机构也陆续出台相关扶持政策，鼓励商家上线夜间送药平台、发展24小时药店，提供夜间送药服务，推动解决“夜间买药难”问题。近日，iiMedia Research(艾媒咨询)最新发布《2021年中国夜间用药年度观察报告》，基于2021年初至2021年末的监测数据，对中国夜间用药市场持续追踪。报告显示，年初有61.2%的用户夜间生病选择忍，而年底这一数字降至52.1%，据推算年末夜间用药受益群体新增约4000万人。报告指出，日渐成熟的中国外卖送药平台，成为解决夜间用药的重要参与者。通过一年的发展，在美团买药“小黄灯”计划等24小时药店惠民工程的推动下，线上24小时药店数量增加、夜间买药配送速度更快、服务保障更加成熟，用户知晓度有了较大提升，夜间买药难的问题得到有效缓解。
Among many social services，night medication has become one of the night social services that people pay most attention to. In recent years，relevant administrative agencies around the country have also successively issued relevant support policies to encourage businesses to launch night medication delivery platforms，develop 24-hour pharmacies，provide night medication delivery services， and promote the solution of the problem of "difficulty in buying drugs at night". Recently， iiMedia Research released the annual observation report on nighttime medication in China in 2021，which continuously tracks China's nighttime medication market based on the monitoring data from the beginning of 2021 to the end of 2021. The report shows that at the beginning of the year， 61.2% of users chose to tolerate illness at night，while at the end of the year，the figure fell to 52.1%. It is estimated that about 40 million people will benefit from night medication at the end of the year.The report points out that the increasingly mature Chinese takeout delivery platform has become an important participant in solving the problem of night medication. Through one year's development，driven by the 24-hour pharmacy benefit project such as the "small yellow light" plan of meituan drug purchase， the number of online 24-hour pharmacies has increased，the speed of drug purchase and distribution at night is faster，the service guarantee is more mature，the user awareness has been greatly improved，and the problem of difficult drug purchase at night has been effectively alleviated.
权利声明
本报告由iiMedia Research（艾媒咨询）出品，文件所涉的文字、图片、商标、表格、视频等均受中华人民共和国知识产权相关法律保护，经许可引用时请注明报告来源。
未经艾媒咨询许可，任何组织或个人均不得以任何形式擅自使用、复制、转载本报告或向第三方实施许可，否则，艾媒咨询将保留追究其一切法律责任之权利。
免责声明
本报告所涉之统计数据，主要由行业访谈、用户调研、市场调查、桌面研究等样本数据，结合专业人员分析及艾媒咨询大数据系统监测、艾媒相关数据分析模型科学计算获得。由于调研样本及计算模型的影响与限制，统计数据仅反映调研样本及模型计算的基本情况，未必能够完全反映市场客观情况。鉴于上述情形，本报告仅作为市场参考资料，艾媒咨询不因本报告（包括但不限于统计数据、模型计算、观点等）承担法律责任。
阅读、使用本报告前，应先审慎阅读及充分理解上述法律声明之内容。阅读、使用本报告，即视为已同意上述法律声明；否则，请勿阅读或使用本报告。
网友评论
只有购买过该报告的用户才能进行评论哦！